Related references
Note: Only part of the references are listed.A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection
Matthew H. Larson et al.
NATURE COMMUNICATIONS (2021)
Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression
Kaitao Yuan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Circulating proteomic signature for detection of biomarkers in bladder cancer patients
Taoufik Nedjadi et al.
SCIENTIFIC REPORTS (2020)
Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy
Shuai Yang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder Carcinoma
Emil Christensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Vitamin K-Dependent Protein S: Beyond the Protein C Pathway
Bjorn Dahlback
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2018)
Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice
Soizic Lecocq et al.
PLOS ONE (2018)
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes
Valeriy Domenyuk et al.
NATURE COMMUNICATIONS (2018)
Poly-ligand profiling (PLP) to differentiate pancreatic cancer patients who benefit from gemcitabine plus evofosfamide versus gemcitabine plus placebo treatment.
Valeriy Domenyuk et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Proteomic profiling of human plasma for cancer biomarker discovery
Zhao Huang et al.
PROTEOMICS (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach
Valeriy Domenyuk et al.
SCIENTIFIC REPORTS (2017)
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags
Kazuyuki Sogawa et al.
BRITISH JOURNAL OF CANCER (2016)
Complement component C3-The Swiss Army Knife of innate immunity and host defense
Daniel Ricklin et al.
IMMUNOLOGICAL REVIEWS (2016)
C4b-binding protein: The good, the bad and the deadly. Novel functions of an old friend
David Ermert et al.
IMMUNOLOGY LETTERS (2016)
Extracting Accurate Precursor Information for Tandem Mass Spectra by Raw Converter
Lin He et al.
ANALYTICAL CHEMISTRY (2015)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Unique Gene-Silencing and Structural Properties of 2 '-Fluoro-Modified siRNAs
Muthiah Manoharan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Complement control protein factor H: The good, the bad, and the inadequate
Viviana P. Ferreira et al.
MOLECULAR IMMUNOLOGY (2010)
Serum-stable RNA aptamers to urokinase-type plasminogen activator blocking receptor binding
Daniel Miotto Dupont et al.
RNA (2010)
Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors
Marcin Okroj et al.
MOLECULAR IMMUNOLOGY (2008)
Simultaneous generation of aptamers to multiple gamma-carboxyglutamic acid proteins from a focused aptamer library using DeSELEX and convergent selection
Juliana M. Layzer et al.
OLIGONUCLEOTIDES (2007)
Aptamers evolved from live cells as effective molecular probes for cancer study
Dihua Shangguan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deconvolution of a complex target using DNA aptamers
S Fitter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Plasma Proteome Database as a resource for proteomics research
B Muthusamy et al.
PROTEOMICS (2005)
In vivo activity of nuclease-resistant siRNAs
JM Layzer et al.
RNA (2004)
The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000
A Bairoch et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
